Gruppo Italiano Malattie EMatologiche dell'Adulto
Also known as: GIMEMA | GIMEMA- Azienda Ospedaliera - Universitaria di Modena, Modena, IT | GIMEMA - Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, IT | GIMEMA (Italian Group for Adult Hematologic Diseases) | GIMEMA Multiple Myeloma Working Party | GIMEMA (Phase I & II) - Universita Degli Studi La Sapienza, IT | GIMEMA - Universita Degli Studi La Sapeinza | Gruppo Italiano Malattie EMatologiche dell'Adulto | Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA)
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1993Last known activity
Nov 1, 2025
Timeline
1980s
- Jun 1, 1982
Gruppo Italiano Malattie EMatologiche dell'Adulto— Founded
Drugs by trial phase (73 distinct, 76 trials)
Phase 3 (42 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Anemia, Hemolytic, Autoimmune
- Hemosiderosis
- Hepatitis
- Hepatitis B
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Plasma Cell
- Leukemia, Promyelocytic, Acute
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Neutropenia
- Philadelphia Chromosome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Recurrence
- Syndrome
- Thrombocytopenia
Recent trials (50)
- NCT06880601Lead sponsorPhase 2Nov 1, 2025
- NCT07075016CollaboratorPhase 3Aug 5, 2025
- NCT06667973Lead sponsorPhase 2Mar 31, 2025
- NCT06409936Lead sponsorPhase 2Sep 30, 2024
- NCT05694312Lead sponsorPhase 2Nov 24, 2023
- NCT05694325Lead sponsorN/AMar 31, 2023
- NCT05478512Lead sponsorPhase 2Nov 30, 2022
- NCT05306301Lead sponsorPhase 2Oct 5, 2022
- NCT04867928Lead sponsorPhase 2Sep 30, 2021
- NCT04763928Lead sponsorPhase 2May 31, 2021
- NCT04722848Lead sponsorPhase 3Mar 31, 2021
- NCT04475731Lead sponsorPhase 2Feb 28, 2021
- NCT04608318CollaboratorPhase 3Dec 31, 2020
- NCT04460963Lead sponsorN/AOct 31, 2020
- NCT04342962Lead sponsorPhase 2Jul 31, 2020
Details
- Founded
- IT Jun 1, 1982
- Last known activity
- Nov 1, 2025